Rafael Holdings RFL
NYSE RFL
$2.29 -0.14 (-5.76%)
As of: Sep 9, 2026 · 3:59 PM EDT

Rafael Holdings (RFL) Revenue (2017 - 2026)

Rafael Holdings' (RFL) quarterly Revenue came in at $179000.0 in Q2 2026, down 50.55% year-over-year from $362000.0 in Q2 2025, and down 15.17% quarter-over-quarter from $211000.0 in Q1 2026.

Analysis

Rafael Holdings (RFL) Revenue (2017 - 2026) Analysis & Trends

Rafael Holdings (RFL) has reported Revenue for 10 consecutive years, with $179000.0 the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Revenue fell 50.55% year-over-year to $179000.0 in Q2 2026; TTM through Apr 2026 was $980000.0, a 33.88% increase from a year earlier, with the FY2025 full-year figure at $917000.0, up 43.96% from the prior year.
  • Revenue was $179000.0 for Q2 2026 at Rafael Holdings, down from $211000.0 in the prior quarter.
  • Over five years, Revenue peaked at $362000.0 in Q2 2025 and troughed at $68000.0 in Q3 2023.
  • A 5-year average of $149000.0 and a median of $76500.0 in 2022 frame the typical range for Revenue.
  • Across the five-year window, Revenue tumbled 92.32% in 2022 and jumped 373.24% in 2024, its largest moves.
  • Over 5 years, Revenue stood at $70000.0 in 2022, then decreased by 2.86% to $68000.0 in 2023, then surged by 88.24% to $128000.0 in 2024, then soared by 87.5% to $240000.0 in 2025, then fell by 25.42% to $179000.0 in 2026.
  • The last three Revenue figures came in at $179000.0 (Q2 2026), $211000.0 (Q1 2026), and $240000.0 (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 10.05 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 7.80 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 3.33 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 4.29 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 1.52 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 145.00 Mn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 1.29 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 2.74 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 1.44 Mn
10 Rafael Holdings 117.57 Mn 117.57 Mn 171,000.00 179,000.00
Historic Data

Historic Data

Download Data
DateValue
Apr 30, 2026 179,000.00
Jan 31, 2026 211,000.00
Oct 31, 2025 240,000.00
Jul 31, 2025 350,000.00
Apr 30, 2025 362,000.00
Jan 31, 2025 77,000.00
Oct 31, 2024 128,000.00
Jul 31, 2024 165,000.00
Apr 30, 2024 336,000.00
Jan 31, 2024 68,000.00
Oct 31, 2023 68,000.00
Jul 31, 2023 68,000.00
Apr 30, 2023 71,000.00
Jan 31, 2023 70,000.00
Oct 31, 2022 70,000.00
Jul 31, 2022 69,000.00
Apr 30, 2022 76,000.00
Jan 31, 2022 74,000.00
Oct 31, 2021 191,000.00
Jul 31, 2021 -2.20 Mn